Integrinβ-1 in disorders and cancers: molecular mechanisms and therapeutic targets
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Integrinβ-1 in disorders and cancers: molecular mechanisms and therapeutic targets ; volume:22 ; number:1 ; day:26 ; month:1 ; year:2024 ; pages:1-24 ; date:12.2024
Cell communication and signaling ; 22, Heft 1 (26.1.2024), 1-24, 12.2024
- Urheber
-
Su, Chen
Mo, Jie
Dong, Shuilin
Liao, Zhibin
Zhang, Bixiang
Zhu, Peng
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12964-023-01338-3
- URN
-
urn:nbn:de:101:1-2024040810213798645964
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Su, Chen
- Mo, Jie
- Dong, Shuilin
- Liao, Zhibin
- Zhang, Bixiang
- Zhu, Peng
- SpringerLink (Online service)
Ähnliche Objekte (12)
Super-enhancer in prostate cancer: transcriptional disorders and therapeutic targets
LncRNA SNHG16 as a potential biomarker and therapeutic target in human cancers
Subunits of human condensins are potential therapeutic targets for cancers
The (pro)renin receptor: a novel biomarker and potential therapeutic target for various cancers
Identifying therapeutic targets for cancer among 2074 circulating proteins and risk of nine cancers
Proteo-genomic characterization of virus-associated liver cancers reveals potential subtypes and therapeutic targets
TMPRSS6 as a Therapeutic Target for Disorders of Erythropoiesis and Iron Homeostasis
Prioritization of therapeutic targets for cancers using integrative multi-omics analysis
Proteome-wide mendelian randomization study implicates therapeutic targets in common cancers
Elucidating therapeutic molecular targets in premenopausal Asian women with recurrent breast cancers
Melatonin and urological cancers: a new therapeutic approach
Hypoxia and its therapeutic possibilities in paediatric cancers
Super-enhancer in prostate cancer: transcriptional disorders and therapeutic targets
LncRNA SNHG16 as a potential biomarker and therapeutic target in human cancers
Subunits of human condensins are potential therapeutic targets for cancers
The (pro)renin receptor: a novel biomarker and potential therapeutic target for various cancers
Identifying therapeutic targets for cancer among 2074 circulating proteins and risk of nine cancers
Proteo-genomic characterization of virus-associated liver cancers reveals potential subtypes and therapeutic targets
TMPRSS6 as a Therapeutic Target for Disorders of Erythropoiesis and Iron Homeostasis
Prioritization of therapeutic targets for cancers using integrative multi-omics analysis
Proteome-wide mendelian randomization study implicates therapeutic targets in common cancers
Elucidating therapeutic molecular targets in premenopausal Asian women with recurrent breast cancers
Melatonin and urological cancers: a new therapeutic approach
Hypoxia and its therapeutic possibilities in paediatric cancers
Super-enhancer in prostate cancer: transcriptional disorders and therapeutic targets
LncRNA SNHG16 as a potential biomarker and therapeutic target in human cancers
Subunits of human condensins are potential therapeutic targets for cancers
The (pro)renin receptor: a novel biomarker and potential therapeutic target for various cancers
Identifying therapeutic targets for cancer among 2074 circulating proteins and risk of nine cancers
Proteo-genomic characterization of virus-associated liver cancers reveals potential subtypes and therapeutic targets
TMPRSS6 as a Therapeutic Target for Disorders of Erythropoiesis and Iron Homeostasis
Prioritization of therapeutic targets for cancers using integrative multi-omics analysis
Proteome-wide mendelian randomization study implicates therapeutic targets in common cancers
Elucidating therapeutic molecular targets in premenopausal Asian women with recurrent breast cancers
Melatonin and urological cancers: a new therapeutic approach